Pilot Study of the Effect of Low-Dose Rosuvastatin on Endothelial Function, Oxidative Stress and Inflammatory Parameters in HIV-Infected Individuals With Low HDL Cholesterol Levels and Low to Normal LDL Cholesterol Levels.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacodynamics
Most Recent Events
- 29 Jan 2015 Biomarkers information updated
- 21 Jun 2012 Planned number of patients changed from 50 to 20.
- 21 Jun 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.